Balance Sheet Data

Regeneron Pharmaceuticals, Inc. (REGN)

$815.375

-8.44 (-1.02%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 4,564.906,471.106,722.6012,532.7014,334.1012,683.1015,540.5719,041.8123,331.8628,588.46
Total Cash (%)
Account Receivables 2,243.202,672.204,114.706,036.505,328.705,881.727,206.858,830.5310,820.0213,257.74
Account Receivables (%)
Inventories 1,151.201,415.501,916.601,951.302,401.902,672.373,274.454,012.174,916.106,023.68
Inventories (%)
Accounts Payable 218.20418.10475.50564589.20671.61822.931,008.331,235.501,513.86
Accounts Payable (%)
Capital Expenditure -383.10-429.60-614.60-551.90-590.10-796.09-975.44-1,195.21-1,464.48-1,794.42
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.